Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Schrag

Showing results (91-100 of 93) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 93 results.
Biotechnology and Bioengineering|March 29, 2023
A CHO stable pool production platform for rapid clinical development of trimeric SARS-CoV-2 spike subunit vaccine antigensSimon Joubert, Matthew Stuible, Simon Lord-Dufour, et al.
ESMO Real World Data and Digital Oncology|February 6, 2026
Collaborating across sectors in service of open science, precision oncology, and patients: an overview of the AACR Project GENIE (Genomics Evidence Neoplasia Information Exchange) Biopharma Collaborative (BPC)A Acebedo, P L Bedard, S Brown, et al.
Nature Communications|March 14, 2023
An anti-HER2 biparatopic antibody that induces unique HER2 clustering and complement-dependent cytotoxicityNina E Weisser, Mario Sanches, Eric Escobar-Cabrera, et al.
Pageof 10

Showing results (91-100 of 93) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 93 results.
Biotechnology and Bioengineering|March 29, 2023
A CHO stable pool production platform for rapid clinical development of trimeric SARS-CoV-2 spike subunit vaccine antigensSimon Joubert, Matthew Stuible, Simon Lord-Dufour, et al.
ESMO Real World Data and Digital Oncology|February 6, 2026
Collaborating across sectors in service of open science, precision oncology, and patients: an overview of the AACR Project GENIE (Genomics Evidence Neoplasia Information Exchange) Biopharma Collaborative (BPC)A Acebedo, P L Bedard, S Brown, et al.
Nature Communications|March 14, 2023
An anti-HER2 biparatopic antibody that induces unique HER2 clustering and complement-dependent cytotoxicityNina E Weisser, Mario Sanches, Eric Escobar-Cabrera, et al.
Pageof 10